Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Marcellusi%2C+Andrea%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Marcellusi%2C+Andrea%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Marcellusi%2C+Andrea%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (14)
1
HPV Vaccination during the COVID-19 Pandemic in Italy : Opportunity Loss or Incremental Cost
enthalten in:
Vaccines
| 2022
von
Mennini, F.
|
Silenzi, A.
|
Marcellusi, A.
| +3
Wird geladen...
2
The Impact of COVID-19 Vaccination on the Italian Healthcare System : A Scenario Analysis
enthalten in:
Clinical drug investigation
| 2022
von
Marcellusi, A.
|
Fabiano, G.
|
Sciattella, P.
| +2
Wird geladen...
3
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
enthalten in:
Clinical drug investigation
| 2022
von
Marcellusi, A.
|
Fabiano, G.
|
Sciattella, P.
| +2
Wird geladen...
4
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
enthalten in:
Clinical drug investigation
| 2022
von
Marcellusi, A.
|
Fabiano, G.
|
Sciattella, P.
| +2
Wird geladen...
5
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
enthalten in:
Clinical drug investigation
| 2022
von
Marcellusi, A.
|
Fabiano, G.
|
Sciattella, P.
| +2
Wird geladen...
6
Cross-regional variations of Covid-19 mortality in Italy : an ecological study
enthalten in:
Journal of public health (Oxford, England)
| 2021
von
Oliva, C.
|
Di Maddaloni, F.
|
Marcellusi, A.
| +1
Wird geladen...
7
Addressing HCV Elimination Barriers in Italy : Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy
enthalten in:
Infectious diseases and therapy
| 2021
von
Andreoni, M.
|
Di Perri, G.
|
Persico, M.
| +8
Wird geladen...
8
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
enthalten in:
Liver international : official journal of the International Association for the Study of the Liver
| 2021
von
Mennini, F.
|
Marcellusi, A.
|
Robbins Scott, S.
| +6
Wird geladen...
9
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
enthalten in:
Infectious diseases and therapy
| 2021
von
Andreoni, M.
|
Di Perri, G.
|
Persico, M.
| +8
Wird geladen...
10
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
enthalten in:
Infectious diseases and therapy
| 2021
von
Andreoni, M.
|
Di Perri, G.
|
Persico, M.
| +8
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
14
Aufsätze
12
E-Artikel
12
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
4
Clinical drug investigation
4
Infectious diseases and therapy
1
Digestive and liver disease : official journal ...
1
Global & regional health technology assessment
1
Journal of public health (Oxford, England)
1
Liver International
1
Liver international : official journal of the I...
1
Vaccines
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
4
Elimination
4
Glecaprevir/pibrentasvir
4
Italy
4
Treatment duration
3
Hepatitis C virus
2
Antiviral Agents
1
COVID-19
1
COVID-19 Vaccines
1
DAAs
1
HCV elimination
1
HPV
1
HTA
1
Hepatitis C virus
1
Letter
1
RWD
1
Research Support, Non-U.S. Gov't
1
Systematic Review
1
break-even
1
hepatitis C infection
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2022
8
2021
1
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
1
Italienisch
Haven't found what you're looking for?
Wird geladen...